Loading…
← CockpitCompetitor Analysis › 301367.SZ BMC Medical Co. Ltd.Open in the cockpit ↗

BMC Medical Co. Ltd.301367.SZCompetitor analysis, valuation and peers

China · CNY·Health Care›Medical Specialties
Momentum neutral 53
Mkt cap
$737M
US dollars, full cap
Free float
42%
of shares outstanding
$/day
$11.8M
20-day average traded
Fwd P/E
18.7×
forward earnings
ROIC−WACC
+17.7 pp
WACC 7.2%
Hurdle
-17 pp
Req g minus delivered
Next earnings
134 days
1 Apr 2027
Close · CNYCN¥38.92
1D-2.1%
1W-6.1%
1M-15.7%
3M-15.8%
6M-16.7%
YTD-36.4%
1Y-36.6%
ATR %3.8%
52w lowhigh45.5% off high

What BMC Medical does

Employees: 1,161

BMC Medical at a glance

Size BMC Medical (301367.SZ) is a China Health Care company (Medical Specialties) with a market value of $737M, the 2776th largest of 4,790 China companies the cockpit tracks. Shares closed at CN¥38.92 on 18 Nov 2026.

Performance Over six months the shares fell 16.7%, against -13.5% for the median peer and -20.0% for the China market (cap-weighted) — 10th lowest of 21 in its peer set.

Growth Revenue grew 37.0% over the last twelve months (peer median +5.9%); the operating margin is 16.9% (peer median 11.4%).

Valuation It trades at 18.7× forward earnings against a peer median of 19.9× (7th cheapest of 16).

Price implies For today's price to make sense, revenue must grow about -1% a year for seven years (Req g). Recent delivered growth is +16%, so the hurdle is -17 pp: the price already allows for a slowdown.

Capital Return on invested capital runs 17.7 points above its cost of capital (7.2% WACC).

Next results Next results expected around 1 Apr 2027 (exchange calendar; dates can move).

Relative performance

9010011021 May 202621 Aug 202618 Nov 2026Peer median 88301367.SZ 85
Six months, rebased to 100: BMC Medical against the median of its 20 peers (local-currency closes).

BMC Medical financials

Reported figures in CNY; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
RevenueCN¥1.44BCN¥1.15BCN¥836MCN¥1.12BCN¥1.41B
Revenue growth—+37%-25%-21%—
Gross profitCN¥789MCN¥587MCN¥388MCN¥501MCN¥575M
EBITDAn/aCN¥225MCN¥119MCN¥259MCN¥381M
Net incomeCN¥232MCN¥226MCN¥155MCN¥297MCN¥380M
Free cash flowCN¥122MCN¥149MCN¥191MCN¥184MCN¥362M
Capital expenditureCN¥35.9MCN¥32.2MCN¥15.9MCN¥24.1MCN¥23.7M
Total debtCN¥556MCN¥84.8MCN¥403MCN¥26.8MCN¥21.1M

Quarterly statements and history in the cockpit →

BMC Medical competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-50%0%+50%-20%0%688179600855INMD6031083004530029503011223004633006222190688410VREX13027575CTKBMLAB301234BBNX301367.SZ6-month return →1-month return →
Up and to the right = strong over both horizons. BMC Medical is the large dot.

Fundamentals: revenue growth against valuation

0%+20%+40%+60%0×200×400×688179INMD6031083004533011226881083004633006222190688410301367.SZRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. BMC Medical is the large dot.

Capital: growth delivered against growth the price implies

0%+50%+100%0%50%100%688179INMD60310830045368810830046321906884107575MLAB301367.SZGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. BMC Medical is the large dot.

BMC Medical competitors and peer comparison

How BMC Medical compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

BMC Medical against its 20 peers (data as of 18 Nov 2026)
Measure301367.SZPeer medianRank in peer set
1-month return-15.7%-8.5%5th lowest of 21
6-month return-16.7%-13.5%10th lowest of 21
Distance from 52-week high-45.5%-37.6%7th lowest of 21
Revenue growth (TTM)+37.0%+5.9%5th highest of 21
Operating margin16.9%11.4%9th highest of 21
Forward P/E18.7×19.9×7th cheapest of 16
Growth the price implies (Req g, 7 yrs)-1.5%8.8%6th least demanding of 15
Growth delivered (Del g)+15.6%+12.8%6th highest of 15
Hurdle (Req g minus delivered)-17.1 pp-8.5 pp5th least demanding of 15
ROIC minus cost of capital+17.7 pp+1.1 pp4th highest of 21

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
BMC Medical 301367.SZChina$737M-17%+37%17%18.7×-1.5%+15.6%
Shanghai Aladdin Biochemical Technology 688179.SSChina$736M-37%+39%24%27.4×17.1%+24.2%
Beijing Aerospace Changfeng 600855.SSChina$738M-44%-10%-19%n/an/an/a
InMode INMDUnited States$741M-8%+2%18%9.8×-10.8%+12.4%
Shanghai Runda Medical Technology 603108.SSChina$744M-36%-12%-2%20.5×20.3%-0.2%
Jiang Xi Sanxin Medtec 300453.SZChina$744M-3%+12%18%16.2×-1.9%+11.8%
Allmed Medical Products 002950.SZChina$747M-32%+14%8%n/an/an/a
Caina Technology 301122.SZChina$721M+36%+61%0%55.4×n/an/a
Sino Medical Sciences Technology 688108.SSChina$753M-41%+22%19%60.0×27.9%+9.9%
Maccura Biotechnology 300463.SZChina$756M-18%-1%-4%421.0×7.9%-10.2%
Doctorglasses Chain 300622.SZChina$710M-22%+6%14%22.8×-3.4%+15.7%
Zylox-Tonbridge Medical Technology 2190.HKHong Kong$768M-16%+39%25%14.4×3.8%+105.8%
SWS Hemodialysis Care 688410.SSChina$706M-11%+31%19%23.5×16.2%+25.9%
Varex Imaging VREXUnited States$771M+79%+5%8%19.9×n/an/a
LifeTech Scientific 1302.HKHong Kong$771M-30%+1%12%19.8×9.6%+15.5%
Japan Lifeline 7575.TJapan$703M+34%+6%19%14.5×-9.5%+2.9%
Cytek Biosciences CTKBUnited States$774M+57%+6%-21%n/an/an/a
Mesa Laboratories MLABUnited States$775M+33%+2%10%11.5×21.3%+13.2%
Shanghai INT Medical Instruments 1501.HKHong Kong$700M-25%+35%21%15.9×-3.3%+23.5%
Anhui Hongyu Wuzhou Medical Manufacturer 301234.SZChina$697M+148%-14%3%n/a31.8%-0.6%
Beta Bionics BBNXUnited States$779M+42%+44%-73%n/an/an/a

Questions

Which companies are BMC Medical's closest peers?
The cockpit's peer set: Shanghai Aladdin Biochemical Technology (688179.SS), Beijing Aerospace Changfeng (600855.SS), InMode (INMD), Shanghai Runda Medical Technology (603108.SS), Jiang Xi Sanxin Medtec (300453.SZ), Allmed Medical Products (002950.SZ), Caina Technology (301122.SZ), Sino Medical Sciences Technology (688108.SS).
Is BMC Medical expensive compared with its peers?
On forward p/e it trades at 18.7× against a peer median of 19.9×, 7th cheapest of 16 in its peer set. For today's price to make sense, revenue must grow about -1% a year for seven years (Req g). Recent delivered growth is +16%, so the hurdle is -17 pp: the price already allows for a slowdown.
How has BMC Medical stock performed?
Over six months to 18 Nov 2026 the shares returned -16.7% against -13.5% for the median peer; over one year -36.6%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.